Tarras Defense secured a significant sentencing result this week in a major federal healthcare fraud prosecution involving allegations tied to cancer genetic testing and more than $124 million in intended loss.
Founding attorney David Tarras represented the client for nearly seven years through multiple federal investigations, parallel proceedings, and indictments in two separate federal districts. The government identified the client as the number two participant in the alleged conspiracy and sought a sentence driven by an advisory guideline range of 151 months.
Following years of litigation, mitigation work, and advocacy, the Court imposed an 18 month sentence and permitted the client to self surrender after designation to a medical Bureau of Prisons facility.
“This case was a reminder that effective white collar defense requires persistence, trust, and a willingness to continue fighting for a client even when the pressure and stakes are extraordinarily high,” said Tarras. “Success in federal sentencing is not always measured by avoiding incarceration altogether. In many cases, it is measured by whether the Court sees the full human story behind the allegations and whether the defense is able to meaningfully change the outcome.”
The matter involved one of the largest healthcare fraud prosecutions centered on cancer genetic testing in the country and spanned years of investigation and litigation activity across multiple jurisdictions.
Tarras Defense represents individuals and businesses in federal investigations, white collar criminal matters, healthcare fraud cases, and complex regulatory proceedings nationwide.